Delphia Therapeutics Revenue and Competitors

Boston, MA USA

Location

#8124

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Delphia Therapeutics's estimated annual revenue is currently $5.4M per year.(i)
  • Delphia Therapeutics's estimated revenue per employee is $187,069
  • Delphia Therapeutics's total funding is $67M.

Employee Data

  • Delphia Therapeutics has 29 Employees.(i)
  • Delphia Therapeutics grew their employee count by 26% last year.

Delphia Therapeutics's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
President & CEOReveal Email/Phone
3
VP, Head ChemistryReveal Email/Phone
4
VP, Biomolecular SciencesReveal Email/Phone
5
VP and Head OperationsReveal Email/Phone
6
VP, Biomolecular SciencesReveal Email/Phone
7
VP, OperationsReveal Email/Phone
8
VP, ChemistryReveal Email/Phone
9
Associate Director, Computational ChemistryReveal Email/Phone
10
Director Structural Biology and Protein ScienceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Delphia Therapeutics?

Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.

keywords:N/A

$67M

Total Funding

29

Number of Employees

$5.4M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$89.3M29-54%N/A
#2
$2.9M29N/AN/A
#3
$4.2M29N/AN/A
#4
$2.9M29N/AN/A
#5
$2.9M29-33%N/A